Yibai Tech Unveils 100.pMarTech Platform: Entering the Era of Pharma Digital Marketing 5.0

In recent years, amid profound changes in industry policies and the broader environment, traditional marketing in the pharmaceutical sector has faced significant challenges. On one hand, cost reduction and efficiency enhancement have become an inevitable trend for pharmaceutical companies under the backdrop of healthcare reform; on the other hand, the pandemic has greatly accelerated enterprises’ demand for digital marketing. Meanwhile, national policies promoting internet-based healthcare have provided richer platforms for digital marketing.

Amidst the process of innovation and exploration, digital marketing has experienced rapid growth due to its high efficiency, low cost, extensive reach, and better alignment with user behavior patterns. In 2020, the scale of digital pharmaceutical marketing in China stood at RMB 15.2 billion; it is projected to reach RMB 113.3 billion by 2025 and RMB 363.3 billion by 2030. The twenty-fold increase in market size over a decade highlights immense room for development and boundless potential. The integration of online and offline channels will make digitally empowered pharmaceutical marketing an inevitable trend over the next ten years.

From Digital Marketing 1.0 to 5.0, the era of digital-intelligence integration has been a long journey. Over the past five years, MedBai Technology has been committed to empowering and upgrading marketing through technology, leveraging data-driven digital-intelligence marketing to provide pharmaceutical companies with comprehensive solutions for “digital academic promotion, digital sales management, and digital doctor-patient management.”

Digital marketing has become a major trend in the pharmaceutical industry, and more pharmaceutical companies are bound to seize the opportunity to join the digital wave in the future. This year, Yibai Technology brought digital marketing in the 5.0 era to pharmaceutical companies through the VCBeat Pharmaceutical Digital Marketing Forum, deeply cultivating the digital field to empower pharmaceutical companies!

Yibai 100 pMarTech Technology SaaS Platform

Yibai’s independently developed 100.pMarTech SaaS platform encompasses four core product pillars: 100.eMarketing for pharmaceutical digital marketing, 100.CRM+ Intelligent Representative Workspace, 100.eHospital Internet Hospital, and 100.AiData Intelligent Data Platform. It provides pharmaceutical enterprises with comprehensive solutions for “digital academic promotion, digital sales management, and digital doctor-patient management,” covering the entire marketing value chain across “enterprise–physician–patient–pharmaceutical.”

Yibai Technology has brought two brand-new products, among which“100.eHospital Internet Hospital”— Enterprise-exclusive internet hospital: Establishing a pharma company-centric integrated doctor-patient platform and prescription follow-up platform, to build a closed-loop pharmaceutical marketing system integrating academic marketing, promotional enablement, and prescription conversion.“100.MIX Cloud Director”—Yibai’s independently developed RTC video and cloud production technologies enable an integrated smart virtual live-streaming platform that combines conferencing and production capabilities. This allows participants to join virtual live streams remotely without the need for green screens, offering exceptional convenience. The platform provides one-stop, multi-scenario audio-video live-streaming solutions, along with end-to-end, high-quality online and offline live-streaming services, facilitating the upgrade from content-focused live streaming to premium-quality live streaming.

—

Forum Name:Digital Marketing for Pharmaceutical CompaniesForum

Forum Time: Morning of June 15, 2022

Forum Organizers: VB100, VCBeat, VCBeat Orange, VCBeat Research Institute

Forum Ecosystem Partnership: Yibai Technology

●9:00-9:10

Opening Remarks by the Organizer, Yibai Technology

Qu Tan | Co-founder and COO of Yibai Technology

●9:10-9:30

Digital Intelligence-Driven Marketing as the Ultimate Goal of Transformation—Report on the Digital Pharmaceutical Marketing Industry

Fang Fen | Senior Researcher, VCBeat

●9:30-9:50

Marketing Mindset in the Digital Era

Peng Yuanfeng | Head of Omnichannel & Market Access Training, AstraZeneca

●9:50-10:10

Big Data Insights—Successful Practices in Digital Marketing for Pharmaceutical Companies

Lin Yanjun | Chief Strategy Officer, Medibai Technology

●10:10-10:30

ChuanPractices of New Digital Marketing Models in the Innovative Transformation of Traditional Pharmaceutical Enterprises

Liu Yong | Vice President of the Marketing Center, Head of the Medical & Market Department, Haisco Pharmaceutical Group

●10:30-10:50

How Digitalization Helps Pharmaceutical Companies Break Through in Marketing Under the New Situation

Feng Rui | Director, Medical Affairs Department (concurrently serving as Director, Health & Wellness Business Planning Department), Sichuan Otsuka

●10:50-11:10

Prescription Outflow and Out-of-Hospital Sales Practices in the Era of Digital Transformation

Wang Hui | Marketing Director, Autoimmune Division, Simcere Pharmaceutical

●11:10-11:40

Digital-Intelligence Convergence – 100.pMarTech Propels Pharmaceutical Digital Marketing into the 5.0 Era

Qu Tan | Co-founder and COO of Yibai Technology

●11:40-11:50

Yibai Tech 100.pMarTech Product Launch: "Internet Hospital" + "100.MIX Cloud Director"

Peng Yuanfeng | Head of Omnichannel & Market Access Training, AstraZeneca
Liu Yong | Deputy General Manager of the Marketing Center, Head of the Medical & Market Department at Haisco Pharmaceutical Group
Wang Hui | Autoimmune Marketing Director, Simcere Pharmaceutical
Feng Rui | Director, Marketing & Medical Department (Concurrent), Otsuka Pharmaceutical (Sichuan) Co., Ltd.
Yang Bin | Deputy General Manager, Pasit Shuanglin Bio-Pharmaceutical Co., Ltd.
Shao Peng | Head of Digital Marketing, Medical Marketing Department, Tasly
Ma Na | Deputy General Manager, Marketing Management Center; Director, Central Marketing Department, Libang Pharmaceutical
Jia Huanhuan | Head of the Pharmaceutical Marketing Department, Qingsong Medicine

Xue Yu | Deputy General Manager of the Second Business Division, Grand Pharma

Li Datao | Founder of Egg Yolk Tech

●11:50-12:30  

RoundtableDiscussion:Intelligent Digital Ecosystem: Pharmaceutical Digital Marketing 5.0 Drives Business Breakthroughs

Host: Lin Yanjun | Chief Strategy Officer, MedBai Technology
Peng Yuanfeng | Head of Omnichannel & Market Access Training, AstraZeneca
Liu Yong | Deputy General Manager, Marketing Center; Head of Medical & Market Department, Haisco Pharmaceutical Group
Feng Rui | Director, Medical Affairs Department (Concurrent), Sichuan Otsuka; Director, Big Health Business Planning Department
Wang Zheng | General Manager, Respiratory Therapeutics Division, Hanhui Pharmaceuticals
Yang Bin | Deputy General Manager, PaaS Shuanglin Bio-Pharmaceutical Co., Ltd.